226 related articles for article (PubMed ID: 12667305)
21. Ligand-mediated transcription elongation control using triplex-based padlock oligonucleotides.
Bello-Roufaï M; Roulon T; Escudé C
Chem Biol; 2004 Apr; 11(4):509-16. PubMed ID: 15123245
[TBL] [Abstract][Full Text] [Related]
22. Transplatin-conjugated triplex-forming oligonucleotides form adducts with both strands of DNA.
Campbell MA; Miller PS
Bioconjug Chem; 2009 Dec; 20(12):2222-30. PubMed ID: 19950917
[TBL] [Abstract][Full Text] [Related]
23. Targeted correction of an episomal gene in mammalian cells by a short DNA fragment tethered to a triplex-forming oligonucleotide.
Chan PP; Lin M; Faruqi AF; Powell J; Seidman MM; Glazer PM
J Biol Chem; 1999 Apr; 274(17):11541-8. PubMed ID: 10206960
[TBL] [Abstract][Full Text] [Related]
24. The human c-Src proto-oncogene promoter contains multiple targets for triplex-forming oligonucleotides.
Ritchie S; Bonham K
Antisense Nucleic Acid Drug Dev; 1998 Oct; 8(5):391-400. PubMed ID: 9826266
[TBL] [Abstract][Full Text] [Related]
25. Targeting and regulation of the HER-2/neu oncogene promoter with bis-peptide nucleic acids.
Ziemba AJ; Zhilina ZV; Krotova-Khan Y; Stankova L; Ebbinghaus SW
Oligonucleotides; 2005; 15(1):36-50. PubMed ID: 15788899
[TBL] [Abstract][Full Text] [Related]
26. Triplex-forming oligonucleotides as potential tools for modulation of gene expression.
Rogers FA; Lloyd JA; Glazer PM
Curr Med Chem Anticancer Agents; 2005 Jul; 5(4):319-26. PubMed ID: 16101484
[TBL] [Abstract][Full Text] [Related]
27. Triplex targeting of human PDGF-B (c-sis, proto-oncogene) promoter specifically inhibits factors binding and PDGF-B transcription.
Liu J; Xu R; Jin Y; Wang D
Nucleic Acids Res; 2001 Feb; 29(3):783-91. PubMed ID: 11160902
[TBL] [Abstract][Full Text] [Related]
28. Distance and affinity dependence of triplex-induced recombination.
Knauert MP; Lloyd JA; Rogers FA; Datta HJ; Bennett ML; Weeks DL; Glazer PM
Biochemistry; 2005 Mar; 44(10):3856-64. PubMed ID: 15751961
[TBL] [Abstract][Full Text] [Related]
29. Targeting chromosomal sites with locked nucleic acid-modified triplex-forming oligonucleotides: study of efficiency dependence on DNA nuclear environment.
Brunet E; Corgnali M; Cannata F; Perrouault L; Giovannangeli C
Nucleic Acids Res; 2006; 34(16):4546-53. PubMed ID: 16951289
[TBL] [Abstract][Full Text] [Related]
30. Design of a novel triple helix-forming oligodeoxyribonucleotide directed to the major promoter of the c-myc gene.
McGuffie EM; Catapano CV
Nucleic Acids Res; 2002 Jun; 30(12):2701-9. PubMed ID: 12060688
[TBL] [Abstract][Full Text] [Related]
31. Triplex-induced recombination and repair in the pyrimidine motif.
Kalish JM; Seidman MM; Weeks DL; Glazer PM
Nucleic Acids Res; 2005; 33(11):3492-502. PubMed ID: 15961731
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the formation and intracellular stability of purine.(purine/pyrimidine) triplexes.
Debin A; Malvy C; Svinarchuk F
Nucleic Acids Res; 1997 May; 25(10):1965-74. PubMed ID: 9115364
[TBL] [Abstract][Full Text] [Related]
33. Chromosome targeting at short polypurine sites by cationic triplex-forming oligonucleotides.
Vasquez KM; Dagle JM; Weeks DL; Glazer PM
J Biol Chem; 2001 Oct; 276(42):38536-41. PubMed ID: 11504712
[TBL] [Abstract][Full Text] [Related]
34. Regulation of transcription through light-activation and light-deactivation of triplex-forming oligonucleotides in mammalian cells.
Govan JM; Uprety R; Hemphill J; Lively MO; Deiters A
ACS Chem Biol; 2012 Jul; 7(7):1247-56. PubMed ID: 22540192
[TBL] [Abstract][Full Text] [Related]
35. High-affinity triplex-forming oligonucleotide target sequences in mammalian genomes.
Wu Q; Gaddis SS; MacLeod MC; Walborg EF; Thames HD; DiGiovanni J; Vasquez KM
Mol Carcinog; 2007 Jan; 46(1):15-23. PubMed ID: 17013831
[TBL] [Abstract][Full Text] [Related]
36. Cross-linking to an interrupted polypurine sequence with a platinum-modified triplex-forming oligonucleotide.
Campbell MA; Miller PS
J Biol Inorg Chem; 2009 Aug; 14(6):873-81. PubMed ID: 19350290
[TBL] [Abstract][Full Text] [Related]
37. Specific inhibition of in vitro transcription elongation by triplex-forming oligonucleotide-intercalator conjugates targeted to HIV proviral DNA.
Giovannangeli C; Perrouault L; Escudé C; Nguyen T; Hélène C
Biochemistry; 1996 Aug; 35(32):10539-48. PubMed ID: 8756710
[TBL] [Abstract][Full Text] [Related]
38. Head-to-head bis-hairpin polyamide minor groove binders and their conjugates with triplex-forming oligonucleotides: studies of interaction with target double-stranded DNA.
Halby L; Ryabinin VA; Sinyakov AN; Novopashina DS; Venyaminova AG; Grokhovsky SL; Surovaya AN; Gursky GV; Boutorine AS
J Biomol Struct Dyn; 2007 Aug; 25(1):61-76. PubMed ID: 17676939
[TBL] [Abstract][Full Text] [Related]
39. Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting.
Lacroix L; Lacoste J; Reddoch JF; Mergny JL; Levy DD; Seidman MM; Matteucci MD; Glazer PM
Biochemistry; 1999 Feb; 38(6):1893-901. PubMed ID: 10026270
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of a triplex-forming oligonucleotide-pyrrolobenzodiazepine conjugate.
Zhilina ZV; Ziemba AJ; Trent JO; Reed MW; Gorn V; Zhou Q; Duan W; Hurley L; Ebbinghaus SW
Bioconjug Chem; 2004; 15(6):1182-92. PubMed ID: 15546183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
